Portfolio approach

A focused approach, built around practical needs.

We consider established and new medicine opportunities through the same disciplined view of need, evidence, feasibility and responsible supply.

01

Development routes

Two routes, one decision standard.

The route changes with the opportunity. The questions about value, evidence and delivery remain consistent.

Established medicines

Improve access to proven treatments.

We assess generic alternatives, practical product improvements and routes to more resilient supply.

Explore established medicines

New medicines

Develop therapeutic options around credible evidence.

We consider repurposing, reformulation, in-licensed programmes and selected new candidates.

Explore new medicines
02

Selection discipline

What every opportunity needs to answer.

A promising idea becomes meaningful only when the full development route can withstand review.

  1. 01

    Meaningful need

    A clear limitation in treatment, formulation, access or supply.

  2. 02

    Credible evidence

    Relevant science and clinical information, including uncertainty and contradictory findings.

  3. 03

    Product feasibility

    A workable formulation, analytical strategy, manufacturing route and quality standard.

  4. 04

    Route to access

    Clear rights, regulatory requirements, territories and a practical supply model.

  5. 05

    Sustainable case

    Economics that can support development, dependable manufacture and continued supply.

Start a conversation

Have an asset, product or supply opportunity that fits this approach?